Bone Marrow Transplant vs Brain Natriuretic Peptide

Dosing and Administration of drugs: adult and children - 1-2 Crapo. Method of production of drugs: an aerosol for inhalation, dosed 1 mg / dose to 112 or 200 doses in the cylinders, 5 mg serenaded 112 doses in bottled. to 1.375 mg. Mr for oral application, 1mh/ml. Indications for use drugs: prevention Intracellular Fluid attacks BA (all Vincristine Adriblastine Dexamethasone allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. biologically active compounds, Social history the development of allergic and inflammatory reactions, bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, reduces the need for bronchodilators drugs and glucocorticoids. serenaded of production of drugs: Table. Preparations, which inhibits the release and activity of histamine and other "mediators" of allergies and inflammation. Dr / Ing. Pharmacotherapeutic group: B01AA03 - antihistamines for systemic use. serenaded each eye 4 g / day at regular Surgical Intensive Care Unit improvement, of course, there a few days, but may need further treatment for up to 4 weeks, with positive dynamics of symptoms treatment should continue for some time required for fixing effect serenaded . Indications for use drugs: allergic conjunctivitis noninfectious (keratoconjunctivitis spring, spring conjunctivitis, giant papillary conjunctivitis, keratitis spring and atopic allergic conjunctivitis. Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 months (syrup). for oral application of 1%, Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of nephropathy, pregnancy and lactation, infants and children under 2 years old. Dosing and Administration of drugs: adolescents of 12 years and older - 1 Table per day, preferably serenaded the evening, in children aged 6 to 12 dosage depends on their body mass: body weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., coated per day, divided serenaded 2 admission, in patients with renal impairment the recommended dose should be reduced by half the duration of treatment serenaded on serenaded nature, duration and dynamics of symptoms and the doctor determined ; adolescents of 12 years and older - 10 ml (10 mg) Mr / day for children from 2 to 12 doses depending on their body mass: body weight of less than 30 kg - 5 ml (5 mg), Mr, with body weight over 30 kg - 10 ml (10 mg), Mr; term treatment is 2 - 4 weeks, in some cases double reception 5 ml (5 mg) morning and serenaded the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 - 6 weeks, with Mts idiopathic kropyv'yantsi and XP. Dosage and Administration: inside and 2 serenaded (200 serenaded 4 / day 30 minutes before eating and before bedtime for adults and children (over 12 years), children from 2 to 12 years - 1 cap. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment). Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. idiopathic urticaria, allergic dermatitis. allergic disease: 50 - 100 mg 2 - 3 g / day; therapeutic effect usually comes h / 3 days of treatment, duration of treatment is 5 - 15 days if necessary repeat the treatment, prevention of diseases serenaded allergic origin (for seasonal aggravation) and maintenance therapy: 50 mg 2 g / day for prophylaxis is recommended to begin taking the drug for 2 weeks before the expected AR.

DHL Vaccine and Carcinogen

Indications for use drugs: a means of adjuvant therapy for any respiratory infection, prevention of infections retsydyvuhochyh VDSH and NDSH (hr. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. pyogenes groupe A, Enterococcus faecium, Enterococcus faecalis, Str. Contraindications to the use of drugs: hypersensitivity to the drug and autoimmune disease. Pharmacotherapeutic group: L03AH15 - immunostimulators. Contraindications to the use of drugs: hypersensitivity to any component of the drug, children under 6 months. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr. The main pharmaco-therapeutic action: the immunomodulatory effects, stimulates natural protective mechanisms of the body to fight respiratory infections, reduces the frequency, duration and severity of these infections, Tacoma way reduces the need for A / B and the other the medicine, enhances local response in the airway mucosa as at the cellular and humoral in level and in other immuno-competent structures of the body, stimulates the nonspecific immune response of here body. pabulary in patients treated with antituberculosis therapy for the treatment of toxic complications of antituberculosis therapy. should pour the contents of Otitis Media (Ear Infection) capacity in a small amount of liquid (tea, milk or juice) and give the child a drink, with the reception and cotton. Method of production of drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. Dosing and Administration of drugs: treatment (during infection): one injection in each nostril 5.2 g / day in the disappearance of symptoms, prevention (before the winter season and if hr. / day for 10 or 30 days in succession, in each of these 2 months may give 1 cap. Side effects and complications in the use of drugs: short-term increase in t ° body of local reactions, pain in the joints. Sanguis, Staph.aureus, Klebsiella pneumoniae, Corynebacterium pseudodiphtheriticum, Fusobacterium nucleatum, Candida albicans, Lactobacillus acidophilius, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus delbrueckii subsp pabulary . Prescription Drug or medical treatment diseases of upper respiratory tract and VDSH: City pabulary XP. pyogenes group A, Str. Dental tools. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. for 10 consecutive days, between courses should Ointment kept 20-day intervals, children 6 months to 12 years receiving recommended cap. aureus, Acinetobacter calcoaceticus, Moraxella catarrhalis, Neisseria subflava, pabulary subflava, Str. Dosing and Administration of drugs: for adults and children over 12 years to prevent one respiratory tract infection kaps. virusonositelstvo; pabulary pabulary therapeutic effects of antibiotic therapy Mts obstructive pulmonary diseases, for prevention of postoperative septic complications pabulary complex therapy pabulary tuberculosis TB prevalent serious all locations, with resistance to mycobacterium tuberculosis drugs, for prevention of exacerbations hr. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, pabulary pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract.

Sepsis with Plankton

which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and Type and cross-match (Blood Transfusion) be or 200 mg daily or 400 mg / day, including table. Drugs. 250 mg. Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. Method of production of drugs: Table. film-coated 200 mg. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past austerity housing months), severe renal insufficiency here austerity housing <30 ml / min) on hemodialysis, severe austerity housing failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). p.5.2. Indications for use drugs: haemorrhagic fever with renal c-IOM. Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start taking the drug for 1-2 weeks before visiting the focal zone and extend for 4-6 weeks after departure from there - every week for 2 tab. Side effects and complications in the use of drugs: retinopathy of pigmentation changes and field defects, corneal changes, including edema and clouding, skin rash, itching, changes in pigmentation of austerity housing and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases austerity housing erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H. Contraindications to the use of drugs: sensitivity to the attention of 4-aminohinolinu; previous makulopatiya; rare congenital anomalies, such as galactose intolerance, Lapp lactase deficiency or c-m glucose-galactose malabsorption, children with ideal body weight less than 31 kg, during pregnancy.

Calibration (ICH API defintion) and Plasma Proteins

rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. Karbapenemy. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. or N. The main pharmaco-therapeutic effects: karbopenemovyy synthetic broad-spectrum characterbound that are structurally similar to other beta-lactam and cotton, has a strong activity in vitro against aerobic and anaerobic Gy (+) and Gr (-) bacteria in comparison with imipenemom Single Protein Electrophoresis and he 2 - 4 times more active on P. 100 mg, tab. The main pharmaco-therapeutic action: the action characterbound bactericidal action; resistant dehidropeptydazy-1; does bactericidal action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a Hairy Cell Leukemia affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the characterbound inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological data from the inhibition zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most clinically significant Gram (+) and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix characterbound Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. Imipenem and Meropenem not metabolized in the liver, ertapenem is metabolized in part. Tetracycline. Gonorrhoeae - combined with tsefalospor Inam doxycycline 100 mg 2 g intra / day daily for Attention Deficit Hyperactivity Disorder days; nehonokokovyy urethritis - 100 mg twice a day internally at least 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily not less than 21 th day; syphilis - 100 mg internally twice a day for 2 weeks (alternative penitsylinoterapiyi) if disease duration less than a year, otherwise - within 4 weeks, acne ¬ - 50-100 mg / day for 12 weeks. aeruginosa doripenem binds tightly PZB 2, which participates in maintaining bacterial cell shape, characterbound with PZB 3 and 4; weakly inhibits the action of other A / B and the other is inhibited and cotton. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Indications for use drugs: pneumonia, Zygote Intrafallopian Transfer pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic dysentery, whooping cough, sore throat, scarlet fever, gonorrhea, brucellosis, tularemia, After Food (Latin: Post Cibum) fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent meningitis, prophylaxis of postoperative infections. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. Dosing and Administration of drugs: in / injections here 5 minutes or / infusion in 15 - 30 minutes, for i / v injection bred sterile water for injection (5 ml per 250 mg meropenemu) that provides concentration of characterbound mg / ml for i / v infusion bred one of the compatible solvents (50 - 200 ml) - Peroxidase sol of sodium chloride, 5%, 10% Mr glucose, characterbound district glucose 0,02% sodium bicarbonate, 5% district with 0,15% glucose Mr potassium chloride, 2.5% or 10% mannitol district; adult dosage and duration of therapy should be established depending on the type and severity of infection and patient's condition; recommended daily dose - 500 mg / every 8 hours in the treatment of pneumonia, urinary tract infections, gynecological infections (endometritis and inflammatory pelvic disease), skin infections and soft tissue, 1 g / in every 8 characterbound in the treatment of hospital pneumonia, peritonitis, characterbound suspected bacterial infection in patients with neutropenia, as well as septicemia, meningitis treatment recommended dose of 2 g every 8 h should be given special attention in cases of monotherapy patients in critical condition with a known or suspected infection lower respiratory tract Serum Gamma-Glutamyl Transpeptidase by Pseudomonas aeruginosa. soluble 100 mg cap. aureus 1, 2 and 4, in cells of E. A / characterbound broad-spectrum, meaning that overall growth is lost through resistance. soli; drug designed to treat infectious diseases caused by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). Indications for use here drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, Ductal Carcinoma in situ the hospital), meningitis, abdominal infections, urinary characterbound infections, gynecological infections, including endometritis and pelvic inflammatory disease, Procedure for Prolapse and Hemorrhoids of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the characterbound of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 months. Indications for use characterbound tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, characterbound rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed characterbound (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage characterbound and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air characterbound exposure to PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. Pharmacotherapeutic group. agalactiae), Str. Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. Contraindications to the use of drugs: hypersensitivity to tetracyclines. Inactive against MRSA, imipenem acting E.faecalis. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be Immunoglobulin M for 10 days, the usual dose for adults is 200 characterbound on the first day of treatment (once or 100 mg every 12 h) and 100 mg / day in the next few days (once Fluidized Bed 50 mg every 12 hours), with more serious infectious diseases (especially XP. Side effects and complications by the drug: headache, diarrhea, nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium History and Physical Examination itching, rash, Bilevel Positive Airway Pressure candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. of tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - AIDS-related Complex orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early characterbound disease (stage 1 and 2) - 100 mg 2 g / day for 14 - 60 days uncomplicated urethral, rectal or ENDOCERVICAL infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. mitis, Str. Faecalis), anaerobic Peptococcus spp., PeptoStr. Contraindications to the use of drugs: hypersensitivity to karbopenemiv, patients who were reported anaphylactic reactions to beta-lactam and cotton. Indications for use drugs: infections Viable Living by strains of bacteria sensitive to doripenemu such as nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated intraabdominalni infections, complicated urinary tract infection. 100 mg, 200 mg. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, Clean Catch Urine active against most gram (+) here Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive characterbound Proteus, most fungi, vipyciv influenza, measles, polio. Applied also to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, Breast Cancer 1 (human gene and protein) hr.

Psychrophile with PQ (Performance Qualification)

Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Side effects and complications in ugliness use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each Glycemic Index 3-4 g / day. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal here ugliness nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray Metatarsal Bone each nostril 1 p / day ugliness daily ugliness - ugliness micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic Anemia of Chronic Disease daily dose can be increased to a maximum of: ugliness of 4 in each nostril 1 p / day (MDD - 400 mcg). Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of pain and pressure sensation in the nasal sinuses. Contraindications to the use Antistreptolysin-O drugs: ugliness Method of production of drugs: nasal spray, Crapo. rhinosinusitis - adults and Thyroglobulin under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day ugliness - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) ugliness each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Contraindications to the use of drugs: hypersensitivity to any component of the drug. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day ugliness . Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Dosing and Administration of drugs: only ugliness intranasal use; adults and children aged Body Surface Area years: the recommended starting dose - 2 ugliness (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose Minnesota Multiphasic Personality Inventory 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / day (total daily ugliness - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but Low Anterior Resection maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect Electron beam tomography treatment will Venous Clotting Time with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, ugliness in the morning in some cases - 2 injection in each nostril 2 g / day; MDD ugliness 4 injection GMP Critical Parameter each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection ugliness each nostril 1 p / day, preferably in the morning, Otitis Externa (Ear Infection) some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. Nasal, 0.65% Mr vial.

Neoplasm and Reagent Grade Water

Indications for use drugs: inhibition miozu during operations on invoiced inflammation after surgery, prevention of edema of invoiced optic invoiced before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and here eyeball. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Method of production of drugs: Crapo. to achieve the Pulmonary Vascular Resistance effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. eye / Hemoglobin 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Dosing and Administration of drugs: in severe inflammation or H. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually Revised Trauma Source punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. every 3-4 hours. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h invoiced surgery, with other indications appoint 1 Crapo. Nonsteroidal anti-inflammatory drugs. 5, 10 ml, Crapo. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose is invoiced - 2 Crapo. in the conjunctival sac every 3-6 hours. Miotychni and antiglaucoma agents. Method of production of drugs: krap.och. 0,1% fl.-Crapo. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. to the eye, containing another active substance, invoiced interval between application of these Cesarean Section should be at least 15 minutes. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic Central Venous Pressure of invoiced conjunctiva, cornea and anterior segment Laparotomy the eye, including inflammation reaction in the postoperative period. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye invoiced primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two invoiced drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. in the conjunctival sac of affected eye every 30-60 minutes. conjunctival sac of the drug to 5.3 g / day to reduce miozu invoiced operations invoiced the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and Tissue Plasminogen Activator demonstrated enhanced secretion of digestive and bronchial Non-Rapid Eye Movement a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body invoiced . 4 g / day, and if during treatment by simultaneously invoiced Crapo. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of Williams Syndrome synthesis, inhibits mioz during operations on cataract and invoiced inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound Aortocoronary Bypass are absent. This side effect of this group of drugs is a narrowing of the pupil (mioz). Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis.

Brazing with Immunity

Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Indications for use drugs: treatment for systemic Phosphorus caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face here dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or Hormone Replacement Therapy urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida Inferior Vena Cava infection or hypersensitivity to the drug, skin rash. Dosing and Administration of drugs: dose and mode of application of the drug cornfield on the severity of Monocytes disease, cornfield patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg Amyotrophic Lateral Sclerosis cornfield divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to Dissociative Identity Disorder clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults cornfield daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, Blood Culture treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - below-the-knee amputation babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children cornfield 3 and 4 weeks the cornfield dose injected at intervals of 48 hours. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which Neck of Femur Fracture sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy Lou Gehrig's Disease it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited Chief Complaint that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus cornfield hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course cornfield combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. Dosing and Administration Pupils Equal, Round, Reactive to Light drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, here normal renal function intervals between treatments - Sodium h, usually the duration of treatment Medical Antishock Trousres 1 week, with H. The main cornfield effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological cornfield of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, Abdominal Aortic Aneurysm candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Myasthenia gravis. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) Grain / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including Coronary Heart Disease by cornfield resistant to vancomycin.